Neurocrine Biosciences, Inc. (0K6R.L)
USD 138.27
(1.59%)
USD 138.27
(1.59%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 389.9 Million | 339.4 Million | 256.5 Million | 228.5 Million | 152.05 Million | 101.36 Million |
| Net Income | 249.7 Million | 154.5 Million | 89.6 Million | 407.3 Million | 37.01 Million | 21.11 Million |
| Depreciation & Amortization | 21.3 Million | 15.6 Million | 10.9 Million | 8.6 Million | 7.45 Million | 4.02 Million |
| Deferred income taxes | -56.7 Million | 19.1 Million | 4.3 Million | -310.7 Million | 11.02 Million | 689 Thousand |
| Stock-based compensation | 194.3 Million | 173.1 Million | 134.2 Million | 100 Million | 75.26 Million | 58.06 Million |
| Change in working capital | 28.2 Million | -67.4 Million | 16.7 Million | -37.9 Million | 241 Thousand | -1.75 Million |
| Other non-cash items | -46.9 Million | 44.5 Million | 800 Thousand | 61.2 Million | 21.06 Million | 19.22 Million |
| Investing Cash Flow | -467.1 Million | -177.1 Million | -130.2 Million | 4.1 Million | -211.07 Million | -242.91 Million |
| Investments in PPE | -28.3 Million | -16.5 Million | -23.4 Million | -10.9 Million | -14.74 Million | -24.81 Million |
| Acquisitions | 31.3 Million | -42.7 Million | 4.6 Million | - | 8000.00 | 34 Thousand |
| Investment purchases | -1.41 Billion | -628.9 Million | -804.7 Million | -735.5 Million | -797.16 Million | -545.96 Million |
| Sales/Maturities of investments | 972.4 Million | 511 Million | 697.9 Million | 750.5 Million | 669.69 Million | 327.82 Million |
| Other Investing Activities | -31.3 Million | -117.9 Million | -4.6 Million | 14.99 Million | -68.85 Million | 34 Thousand |
| Financing Cash Flow | 65.3 Million | -234.3 Million | 27.4 Million | -157.8 Million | 27.31 Million | 29.53 Million |
| Debt repayment | - | -279 Million | -100 Thousand | -186.9 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 65.3 Million | 44.7 Million | 27.5 Million | 29.1 Million | 27.31 Million | 29.53 Million |
| Other Financing Activities | 65.3 Million | -234.3 Million | 27.4 Million | -157.8 Million | 32.4 Million | 29.5 Million |
| Accounts receivables | -89.3 Million | -162.2 Million | -28.4 Million | -30.5 Million | -69.16 Million | -25.11 Million |
| Accounts payables | 64.3 Million | 114.6 Million | 56.8 Million | 26.9 Million | 53.95 Million | 18.17 Million |
| Inventory | 5.4 Million | -2.6 Million | -2.5 Million | -10.7 Million | -6.42 Million | -3.52 Million |
| Other working capital | 47.8 Million | -17.2 Million | -9.2 Million | -23.6 Million | 21.87 Million | 8.7 Million |
| Cash at beginning of period | 270.7 Million | 344 Million | 190.3 Million | 115.5 Million | 147.19 Million | 259.21 Million |
| Cash at end of period | 259.1 Million | 270.7 Million | 344 Million | 190.3 Million | 115.48 Million | 147.19 Million |
| Capital Expenditure | -28.3 Million | -16.5 Million | -23.4 Million | -10.9 Million | -14.74 Million | -24.81 Million |
| Effect of forex changes on cash | 300 Thousand | -1.3 Million | - | - | - | - |
| Net cash flow / Change in cash | -11.6 Million | -73.3 Million | 153.7 Million | 74.8 Million | -31.7 Million | -112.02 Million |
| Free Cash Flow | 361.6 Million | 322.9 Million | 233.1 Million | 217.6 Million | 137.3 Million | 76.55 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 129.8 Million | 65 Million | 43.4 Million | 147.7 Million | 249.7 Million | 83.1 Million |
| Depreciation & Amortization | 6.5 Million | 7.3 Million | 6.2 Million | 5.7 Million | 21.3 Million | 5.5 Million |
| Deferred income taxes | -34.9 Million | -41.3 Million | -15.6 Million | 20.6 Million | -56.7 Million | -4.2 Million |
| Stock-based compensation | 41.5 Million | 43.1 Million | 44.5 Million | 38.1 Million | 194.3 Million | 47.8 Million |
| Change in working capital | 4.4 Million | -86.3 Million | -31.6 Million | -53.7 Million | 28.2 Million | 46 Million |
| Other non-cash items | 10.7 Million | 216.9 Million | 169.1 Million | -34.9 Million | -46.9 Million | 33.8 Million |
| Investing Cash Flow | 24.7 Million | -28.2 Million | -55 Million | -201.8 Million | -467.1 Million | -97.3 Million |
| Investments in PPE | -8.1 Million | -11.6 Million | -11.2 Million | -5.4 Million | -28.3 Million | -7.6 Million |
| Acquisitions | - | - | - | 5.4 Million | 31.3 Million | 89.7 Million |
| Investment purchases | -232.5 Million | -191.7 Million | -320.1 Million | -487.2 Million | -1.41 Billion | -362.7 Million |
| Sales/Maturities of investments | 265.3 Million | 175.1 Million | 276.3 Million | 290.8 Million | 972.4 Million | 273 Million |
| Other Investing Activities | -8.1 Million | -16.6 Million | -43.8 Million | -5.4 Million | -31.3 Million | -89.7 Million |
| Financing Cash Flow | 26.4 Million | -293 Million | 69.9 Million | 35.4 Million | 65.3 Million | 18.8 Million |
| Debt repayment | -308.8 Million | -308.8 Million | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 26.4 Million | 15.8 Million | 69.9 Million | 35.4 Million | 65.3 Million | 18.8 Million |
| Other Financing Activities | 26.4 Million | -293 Million | 69.9 Million | 35.4 Million | 65.3 Million | 18.8 Million |
| Accounts receivables | -12.9 Million | -17.6 Million | -11.3 Million | -21.4 Million | -89.3 Million | -30.4 Million |
| Accounts payables | 39.4 Million | -59.5 Million | -18.6 Million | -83 Million | 64.3 Million | 124.4 Million |
| Inventory | -3.3 Million | -5.3 Million | 1.1 Million | -900 Thousand | 5.4 Million | 2.9 Million |
| Other working capital | 20.6 Million | -3.9 Million | -2.8 Million | 51.6 Million | 47.8 Million | -50.9 Million |
| Cash at beginning of period | 147.7 Million | 396.3 Million | 251.1 Million | 301.7 Million | 270.7 Million | 168.2 Million |
| Cash at end of period | 357.1 Million | 139.7 Million | 396.3 Million | 259.1 Million | 259.1 Million | 301.7 Million |
| Capital Expenditure | -8.1 Million | -11.6 Million | -11.2 Million | -5.4 Million | -28.3 Million | -7.6 Million |
| Effect of forex changes on cash | 300 Thousand | - | - | 300 Thousand | 300 Thousand | - |
| Net cash flow / Change in cash | 209.4 Million | -256.6 Million | 145.2 Million | -42.6 Million | -11.6 Million | 133.5 Million |
| Free Cash Flow | 149.9 Million | 52.99 Million | 119.1 Million | 118.1 Million | 361.6 Million | 204.4 Million |
D05
036570
FFIN
7550
SBS
KRYPTONQ